Skip to main content
Top
Published in: Rheumatology International 10/2011

01-10-2011 | Original Article

Variations in chondrocyte apoptosis may explain the increased prevalence of osteoarthritis in some joints

Authors: C. M. Thomas, C. E. Whittles, C. J. Fuller, M. Sharif

Published in: Rheumatology International | Issue 10/2011

Login to get access

Abstract

Objectives

To investigate whether there are any variations in chondrocyte susceptibility to an apoptotic stimulus between cells of articular cartilage (AC) from equine joints that differ in prevalence of osteoarthritis (OA).

Methods

Cartilage from macroscopically normal equine metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) joints was used. Prior to culture, chondrocyte viability was assessed using the fluorescein diacetate (FDA) and propidium iodide paravital staining method. AC explants were subsequently treated with tumour necrosis factor-α (TNF-α) in combination with Actinomycin D to induce apoptosis. Apoptosis of chondrocytes in cartilage sections was assessed by expression of active caspase-3 using indirect immunohistochemistry and sections also histologically graded using a ‘modified’ Mankin scoring system.

Results

Prior to culture (mean ± standard deviation) chondrocyte viability was 80.7% (3.5). The extent of chondrocyte apoptosis induced by TNF-α/Actinomycin D varied markedly according to the joint type that the cartilage was sampled from. For MCP joints, the extent of overall chondrocyte apoptosis was significantly higher (P < 0.001) in stimulated explants (26.7%, 10.3) than that observed in unstimulated control samples (9.6%, 7.5). Conversely, chondrocytes from PIP and DIP joint cartilage did not respond significantly to apoptotic stimulation (P > 0.05). Significant variations in cellularity and thickness were also evident between cartilages of different joint types.

Conclusions

Data in this study demonstrate that chondrocytes from three equine joint types with varying prevalences of OA differ significantly in terms of susceptibility to apoptosis induction. This may provide a possible explanation for the joint-specific nature of the disease.
Literature
1.
go back to reference Cushnaghan J, Dieppe P (1991) Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis 50:8–13PubMedCrossRef Cushnaghan J, Dieppe P (1991) Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis 50:8–13PubMedCrossRef
2.
go back to reference Kuettner KE, Cole AA (2005) Cartilage degeneration in different human joints. Osteoarthr Cartil 13:93–103PubMedCrossRef Kuettner KE, Cole AA (2005) Cartilage degeneration in different human joints. Osteoarthr Cartil 13:93–103PubMedCrossRef
3.
go back to reference Shepherd DE, Seedhom BB (1999) Thickness of human articular cartilage in joints of the lower limb. Ann Rheum Dis 58:27–34PubMedCrossRef Shepherd DE, Seedhom BB (1999) Thickness of human articular cartilage in joints of the lower limb. Ann Rheum Dis 58:27–34PubMedCrossRef
4.
go back to reference Huch K (2001) Knee and ankle: human joints with different susceptibility to osteoarthritis reveal different cartilage cellularity and matrix synthesis in vitro. Arch Orthop Trauma Surg 121:301–306PubMedCrossRef Huch K (2001) Knee and ankle: human joints with different susceptibility to osteoarthritis reveal different cartilage cellularity and matrix synthesis in vitro. Arch Orthop Trauma Surg 121:301–306PubMedCrossRef
5.
go back to reference Treppo S, Koepp H, Quan EC, Cole AA, Kuettner KE, Grodzinsky AJ (2000) Comparison of biomechanical and biochemical properties of cartilage from human knee and ankle pairs. J Orthop Res 18:739–748PubMedCrossRef Treppo S, Koepp H, Quan EC, Cole AA, Kuettner KE, Grodzinsky AJ (2000) Comparison of biomechanical and biochemical properties of cartilage from human knee and ankle pairs. J Orthop Res 18:739–748PubMedCrossRef
6.
go back to reference Eger W, Schumacher BL, Mollenhauer J, Kuettner KE, Cole AA (2002) Human knee and ankle cartilage explants: catabolic differences. J Orthop Res 20:526–534PubMedCrossRef Eger W, Schumacher BL, Mollenhauer J, Kuettner KE, Cole AA (2002) Human knee and ankle cartilage explants: catabolic differences. J Orthop Res 20:526–534PubMedCrossRef
7.
go back to reference Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE et al (1996) Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest 74:232–240PubMed Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE et al (1996) Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest 74:232–240PubMed
8.
go back to reference Häuselmann HJ, Mok SS, Flechtenmacher J, Gitelis SH, Kuettner KE (1993) Chondrocytes from human knee and ankle joints show differences in response to IL-1 and IL-1 receptor inhibitor (Abstract). Orthop Res Soc Trans 18:280 Häuselmann HJ, Mok SS, Flechtenmacher J, Gitelis SH, Kuettner KE (1993) Chondrocytes from human knee and ankle joints show differences in response to IL-1 and IL-1 receptor inhibitor (Abstract). Orthop Res Soc Trans 18:280
9.
go back to reference Kang Y, Koepp H, Cole AA, Kuettner KE, Homandberg GA (1998) Cultured human ankle and knee cartilage differ in susceptibility to damage mediated by fibronectin fragments. J Orthop Res 16:551–556PubMedCrossRef Kang Y, Koepp H, Cole AA, Kuettner KE, Homandberg GA (1998) Cultured human ankle and knee cartilage differ in susceptibility to damage mediated by fibronectin fragments. J Orthop Res 16:551–556PubMedCrossRef
10.
go back to reference Aurich M, Eger W, Rolauffs B, Margulis A, Kuettner KE, Mollenhauer JA et al (2006) Ankle chondrocytes are more resistant to Interleukin-1 than chondrocytes derived from the knee. Orthopäde 35:784–790PubMedCrossRef Aurich M, Eger W, Rolauffs B, Margulis A, Kuettner KE, Mollenhauer JA et al (2006) Ankle chondrocytes are more resistant to Interleukin-1 than chondrocytes derived from the knee. Orthopäde 35:784–790PubMedCrossRef
11.
go back to reference Cantley CE, Firth EC, Delahunt JW, Pfeiffer DU, Thompson KG (1999) Naturally occurring osteoarthritis in the metacarpophalangeal joints of wild horses. Equine Vet J 31:73–81PubMedCrossRef Cantley CE, Firth EC, Delahunt JW, Pfeiffer DU, Thompson KG (1999) Naturally occurring osteoarthritis in the metacarpophalangeal joints of wild horses. Equine Vet J 31:73–81PubMedCrossRef
12.
go back to reference Pool RR (1996) Pathological manifestations of joint disease in the athletic horse. In: McIllwraith CW, Trotter GW (eds) Joint disease in the horse. W.B. Saunders, Philadelphia, pp 87–104 Pool RR (1996) Pathological manifestations of joint disease in the athletic horse. In: McIllwraith CW, Trotter GW (eds) Joint disease in the horse. W.B. Saunders, Philadelphia, pp 87–104
13.
go back to reference Schaer TP, Bramlage LR, Embertson RM, Hance S (2001) Proximal interphalangeal arthrodesis in 22 horses. Equine Vet J 33:360–365PubMedCrossRef Schaer TP, Bramlage LR, Embertson RM, Hance S (2001) Proximal interphalangeal arthrodesis in 22 horses. Equine Vet J 33:360–365PubMedCrossRef
14.
go back to reference Knox PM, Watkins JP (2006) Proximal interphalangeal joint arthrodesis using a combination plate-screw technique in 53 horses (1994–2003). Equine Vet J 38:538–542PubMedCrossRef Knox PM, Watkins JP (2006) Proximal interphalangeal joint arthrodesis using a combination plate-screw technique in 53 horses (1994–2003). Equine Vet J 38:538–542PubMedCrossRef
15.
go back to reference Hashimoto S, Ochs RL, Komiya S, Lotz M (1998) Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 41:1632–1638PubMedCrossRef Hashimoto S, Ochs RL, Komiya S, Lotz M (1998) Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 41:1632–1638PubMedCrossRef
16.
go back to reference Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M (1998) Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 41:1266–1274PubMedCrossRef Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M (1998) Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 41:1266–1274PubMedCrossRef
17.
go back to reference Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY (2003) Articular chondrocyte apoptosis in equine osteoarthritis. Vet J 166:52–57PubMedCrossRef Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY (2003) Articular chondrocyte apoptosis in equine osteoarthritis. Vet J 166:52–57PubMedCrossRef
18.
go back to reference Matsuo M, Nishida K, Yoshida A, Murakami T, Inoue H (2001) Expression of caspase-3 and -9 relevant to cartilage destruction and chondrocyte apoptosis in human osteoarthritic cartilage. Acta Med Okayama 55:333–340PubMed Matsuo M, Nishida K, Yoshida A, Murakami T, Inoue H (2001) Expression of caspase-3 and -9 relevant to cartilage destruction and chondrocyte apoptosis in human osteoarthritic cartilage. Acta Med Okayama 55:333–340PubMed
19.
go back to reference Thomas CM, Fuller CJ, Whittles CE, Sharif M (2007) Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthr Cartil 15:27–34PubMedCrossRef Thomas CM, Fuller CJ, Whittles CE, Sharif M (2007) Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthr Cartil 15:27–34PubMedCrossRef
20.
go back to reference Fischer BA, Mundle S, Cole AA (2000) Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 50:236–242PubMedCrossRef Fischer BA, Mundle S, Cole AA (2000) Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 50:236–242PubMedCrossRef
21.
go back to reference Nuttall ME, Nadeau DP, Fisher PW, Wang F, Keller PM, DeWolf WE Jr et al (2000) Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. J Orthop Res 18:356–363PubMedCrossRef Nuttall ME, Nadeau DP, Fisher PW, Wang F, Keller PM, DeWolf WE Jr et al (2000) Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. J Orthop Res 18:356–363PubMedCrossRef
22.
go back to reference Kim HA, Song YW (2002) TNF-a-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D. Biochem Biophys Res Comm 295:937–944CrossRef Kim HA, Song YW (2002) TNF-a-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D. Biochem Biophys Res Comm 295:937–944CrossRef
23.
go back to reference Kühn K, Hashimoto S, Lotz M (2000) IL-1 beta protects human chondrocytes from CD95-induced apoptosis. J Immunol 164:2233–2239PubMed Kühn K, Hashimoto S, Lotz M (2000) IL-1 beta protects human chondrocytes from CD95-induced apoptosis. J Immunol 164:2233–2239PubMed
24.
go back to reference López-Armada MJ, Caramés B, Lires-Deán M, Cillero-Pastor B, Ruiz-Romero C, Galdo F et al (2006) Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthr Cartil 14:660–669PubMedCrossRef López-Armada MJ, Caramés B, Lires-Deán M, Cillero-Pastor B, Ruiz-Romero C, Galdo F et al (2006) Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthr Cartil 14:660–669PubMedCrossRef
25.
go back to reference Yoshimura F, Kanno H, Uzuki M, Tajima K, Shimamura T, Sawai T (2006) Downregulation of inhibitor of apoptosis proteins in apoptotic human chondrocytes treated with tumor necrosis factor-alpha and actinomycin D. Osteoarthr Cartil 14:435–441PubMedCrossRef Yoshimura F, Kanno H, Uzuki M, Tajima K, Shimamura T, Sawai T (2006) Downregulation of inhibitor of apoptosis proteins in apoptotic human chondrocytes treated with tumor necrosis factor-alpha and actinomycin D. Osteoarthr Cartil 14:435–441PubMedCrossRef
26.
go back to reference Fuller CJ, Barr AR, Sharif M, Dieppe PA (2001) Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthr Cartil 9:49–55PubMedCrossRef Fuller CJ, Barr AR, Sharif M, Dieppe PA (2001) Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthr Cartil 9:49–55PubMedCrossRef
27.
go back to reference Clements KM, Bee ZC, Crossingham GV, Adams MA, Sharif M (2001) How severe must repetitive loading be to kill chondrocytes in articular cartilage? Osteoarthr Cartil 9:499–507PubMedCrossRef Clements KM, Bee ZC, Crossingham GV, Adams MA, Sharif M (2001) How severe must repetitive loading be to kill chondrocytes in articular cartilage? Osteoarthr Cartil 9:499–507PubMedCrossRef
28.
go back to reference Weaver RE, Sharif M, Livingston LA, Andrews KL, Fuller CJ (2006) Microscopic change in macroscopically normal equine cartilage from osteoarthritic joints. Connect Tissue Res 47:92–101PubMedCrossRef Weaver RE, Sharif M, Livingston LA, Andrews KL, Fuller CJ (2006) Microscopic change in macroscopically normal equine cartilage from osteoarthritic joints. Connect Tissue Res 47:92–101PubMedCrossRef
29.
go back to reference Linderstrøm-Lang H, Holter H, Ohlson AS (1934) Beitrage zur enzymatischen Histochemie; über die Verteilung von Säure in der Schleimhaut des Schweinemagens. Z Physiol Chem 227:1CrossRef Linderstrøm-Lang H, Holter H, Ohlson AS (1934) Beitrage zur enzymatischen Histochemie; über die Verteilung von Säure in der Schleimhaut des Schweinemagens. Z Physiol Chem 227:1CrossRef
30.
go back to reference Trickett MJ, Sharif M, Perry MJ, Fuller CJ (2004) Increased expression of catabolic cytokines and their receptors in early equine articular cartilage damage (Abstract). Rheumatology 43(Suppl 2):ii50–ii52 Trickett MJ, Sharif M, Perry MJ, Fuller CJ (2004) Increased expression of catabolic cytokines and their receptors in early equine articular cartilage damage (Abstract). Rheumatology 43(Suppl 2):ii50–ii52
31.
go back to reference Dang Y, Cole AA, Homandberg GA (2003) Comparison of the catabolic effects of fibronectin fragments in human knee and ankle cartilages. Osteoarthr Cartil 11:538–547PubMedCrossRef Dang Y, Cole AA, Homandberg GA (2003) Comparison of the catabolic effects of fibronectin fragments in human knee and ankle cartilages. Osteoarthr Cartil 11:538–547PubMedCrossRef
32.
go back to reference Fuller CJ, Barr AR, Dieppe PA (2001) Variations in cartilage catabolism in different equine joints in response to interleukin-1 in vitro. Vet Rec 148:204–206PubMedCrossRef Fuller CJ, Barr AR, Dieppe PA (2001) Variations in cartilage catabolism in different equine joints in response to interleukin-1 in vitro. Vet Rec 148:204–206PubMedCrossRef
Metadata
Title
Variations in chondrocyte apoptosis may explain the increased prevalence of osteoarthritis in some joints
Authors
C. M. Thomas
C. E. Whittles
C. J. Fuller
M. Sharif
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1471-9

Other articles of this Issue 10/2011

Rheumatology International 10/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.